QSS
LXRX icon

Quantitative Systematic Strategies’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-34,086
Closed -$117K – 707
2020
Q4 		$117K Buy
+34,086
New +$65K 0.02% 583
2019
Q3 		– Sell
-20,648
Closed -$130K – 543
2019
Q2 		$130K Buy
20,648
+8,302
+67% +$49.7K 0.02% 433
2019
Q1 		$69K Sell
12,346
-36,550
-75% -$222K 0.02% 359
2018
Q4 		$325K Buy
48,896
+26,543
+119% +$215K 0.07% 385
2018
Q3 		$239K Buy
22,353
+532
+2% +$6.1K 0.05% 476
2018
Q2 		$262K Buy
21,821
+2,650
+14% +$27.1K 0.05% 500
2018
Q1 		$164K Buy
19,171
+7,296
+61% +$67.5K 0.03% 581
2017
Q4 		$117K Buy
+11,875
New +$123K 0.03% 518

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return